(CRVL) CorVel - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2210061097
CRVL: Claims, Management, Solutions, Healthcare, Insurance, Technology
CorVel Corporation is a leader in providing advanced technology-driven solutions for managing workers compensation, auto, liability, and health claims. Their platform leverages AI, machine learning, and NLP to optimize care episode management and reduce healthcare costs, offering a comprehensive approach to claims resolution.
The companys extensive service portfolio includes network solutions such as automated fee auditing and provider management, alongside patient management services like 24/7 nurse triage and vocational rehabilitation. These services are designed to assist employers, insurers, and government agencies in controlling medical expenses and ensuring quality care.
With a market cap nearing $6 billion, CorVels high P/E ratio of 72 reflects significant investment in growth initiatives. A P/B ratio of 20 highlights the markets confidence in their intangible assets and future prospects. This financial standing underscores their strategic position in the healthcare services sector.
Additional Sources for CRVL Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CRVL Stock Overview
| Market Cap in USD | 5,315m |
| Sector | Financial Services |
| Industry | Insurance Brokers |
| GiC Sub-Industry | Health Care Services |
| IPO / Inception | 1991-06-28 |
CRVL Stock Ratings
| Growth 5y | 93.5% |
| Fundamental | 49.4% |
| Dividend | 0.0% |
| Rel. Strength Industry | 27.9 |
| Analysts | - |
| Fair Price Momentum | 128.52 USD |
| Fair Price DCF | 17.11 USD |
CRVL Dividends
No Dividends PaidCRVL Growth Ratios
| Growth Correlation 3m | -38.9% |
| Growth Correlation 12m | 86.8% |
| Growth Correlation 5y | 94.2% |
| CAGR 5y | 41.07% |
| CAGR/Max DD 5y | 1.11 |
| Sharpe Ratio 12m | 0.61 |
| Alpha | 15.76 |
| Beta | 1.40 |
| Volatility | 31.63% |
| Current Volume | 81.5k |
| Average Volume 20d | 91.6k |
As of March 15, 2025, the stock is trading at USD 106.65 with a total of 81,509 shares traded.
Over the past week, the price has changed by -1.94%, over one month by -9.10%, over three months by -12.64% and over the past year by +29.06%.
Partly, yes. Based on ValueRay Fundamental Analyses, CorVel (NASDAQ:CRVL) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 49.36 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRVL as of March 2025 is 128.52. This means that CRVL is currently undervalued and has a potential upside of +20.51% (Margin of Safety).
CorVel has no consensus analysts rating.
According to ValueRays Forecast Model, CRVL CorVel will be worth about 145.3 in March 2026. The stock is currently trading at 106.65. This means that the stock has a potential upside of +36.27%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 145.3 | 36.3% |